Rising Drug Costs Force a Third of Americans to Leave Prescriptions Unfilled: Report

Seeking Alpha27minutes ago

Why Astrazeneca (AZN) Is a Top Growth Stock for the Long-Term

Yahoo FinanceJun 28 21:45

Systemic Sclerosis Market to Exhibit Significant Growth by 2034, Predicts DelveInsight | Key Companies - Kyowa Hakko Kirin, AstraZeneca, Mitsubishi Tanabe Pharma, Genentech, Amgen, GlaxoSmithKline, Boehringer Ingelheim

According to DelveInsight's analysis, the growth of the systemic sclerosis market is expected to be mainly driven by increasing prevalence, patient awareness, and the launch of potential therapies wi

PR NewswireJun 28 05:31

Express News | Germany supports the public to receive the vaccine jointly developed by Astrazeneca and Sanofi for respiratory syncytial virus (RSV), but currently does not support vaccination with Pfizer's vaccine.

BreakingsJun 27 22:40

GLP-1 Agonists Market to Grow Rapidly by 2034, Predicts DelveInsight | Key Companies - Novo Nordisk A/S, Veru Inc., Viking Therapeutics, Inc., Terns Pharmaceuticals, Inc., Eccogene, AstraZeneca

New York, USA, June 26, 2024 (GLOBE NEWSWIRE) -- GLP-1 Agonists Market to Grow Rapidly by 2034, Predicts DelveInsight | Key Companies - Novo Nordisk A/S, Veru Inc., Viking Therapeutics, Inc., Terns

GlobeNewswireJun 27 01:00

AstraZeneca's (AZN) Imfinzi Meets Study Goal in Bladder Cancer

Yahoo FinanceJun 27 00:57